G
JAZZ icon

GlobalBridge’s Jazz Pharmaceuticals JAZZ Stock Holding History

GlobalBridge’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$214K Sell
1,544
-1,032
-40% -$155K 0.1% 312
2013
Q4 		$326K Sell
2,576
-1,658
-39% -$172K 0.16% 208
2013
Q3 		$389K Sell
4,234
-29
-0.7% -$2.34K 0.21% 174
2013
Q2 		$293K Buy
+4,263
New +$261K 0.16% 216

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GlobalBridge's JAZZ Position: Q1 2014 in Review

GlobalBridge reduced its Jazz Pharmaceuticals (JAZZ) stake by 40% in Q1 2014, selling an estimated $155K and leaving 1,544 shares worth $214K. The position accounts for 0.1% of the portfolio, ranked #312.

GlobalBridge first reported a position in JAZZ in Q2 2013 and has held it in 4 quarters since. The position peaked at $389K in Q3 2013. 318 funds tracked by Wall St. Rank hold JAZZ as of Q1 2014.

  • GlobalBridge held 1,544 shares of Jazz Pharmaceuticals worth $214K as of Q1 2014.
  • GlobalBridge sold 1,032 Jazz Pharmaceuticals shares in Q1 2014, an estimated $155K.
  • Jazz Pharmaceuticals made up 0.1% of GlobalBridge's portfolio in Q1 2014, its #312 holding.
  • GlobalBridge first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
  • GlobalBridge's Jazz Pharmaceuticals position peaked at $389K in Q3 2013.
  • 318 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2014.

Based on GlobalBridge's 13F filing for Q1 2014, filed 8 Apr 2014.